HSBC Holdings plc set a CHF 210 target price on Roche Holding Ltd. (VTX:ROG) in a report released on Monday morning. The brokerage currently has a sell rating on the healthcare company’s stock.

ROG has been the subject of several other research reports. Deutsche Bank AG set a CHF 255 target price on Roche Holding and gave the stock a neutral rating in a research report on Monday, September 11th. Jefferies Group LLC set a CHF 305 target price on Roche Holding and gave the stock a buy rating in a research report on Monday, May 29th. Goldman Sachs Group, Inc. (The) set a CHF 335 target price on Roche Holding and gave the stock a buy rating in a research report on Friday, May 26th. Kepler Capital Markets set a CHF 231 target price on Roche Holding and gave the stock a neutral rating in a research report on Tuesday, June 6th. Finally, BNP Paribas set a CHF 250 target price on Roche Holding and gave the stock a neutral rating in a research report on Tuesday, June 20th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the company. The company currently has an average rating of Hold and a consensus price target of CHF 267.53.

Shares of Roche Holding (ROG) opened at 247.00 on Monday. Roche Holding has a 52 week low of CHK 218.30 and a 52 week high of CHK 273.00. The firm has a 50-day moving average price of CHK 243.52 and a 200-day moving average price of CHK 252.25. The firm has a market cap of CHK 210.76 billion and a PE ratio of 21.93.

WARNING: “HSBC Holdings plc Analysts Give Roche Holding Ltd. (ROG) a CHF 210 Price Target” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another site, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.watchlistnews.com/hsbc-holdings-plc-analysts-give-roche-holding-ltd-rog-a-chf-210-price-target-2/1576652.html.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.